A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.

Researchers at Vanderbilt and the University of Michigan have shown that a simple at-home urine test for prostate cancerscreeningis highly accurate. The exciting new results, published in The Journal ...